According to Onconova Therapeutics's latest financial reports the company's total assets are $27.03 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $39.37 M | -29.03% |
2021-12-31 | $55.47 M | 177.58% |
2020-12-31 | $19.98 M | -15.58% |
2019-12-31 | $23.67 M | 32.09% |
2018-12-31 | $17.92 M | 259.97% |
2017-12-31 | $4.97 M | -78.57% |
2016-12-31 | $23.23 M | -0.9% |
2015-12-31 | $23.44 M | -50.47% |
2014-12-31 | $47.33 M | -54.98% |
2013-12-31 | $0.10 B | 25.4% |
2012-12-31 | $83.85 M | 1779.25% |
2011-12-31 | $4.46 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Baxter BAX | $28.27 B | 104,478.74% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.10 B | 298.24% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $0.11 B | 315.24% | ๐บ๐ธ USA |
Cleveland BioLabs
CBLI | N/A | N/A | ๐บ๐ธ USA |
Array Technologies ARRY | $1.70 B | 6,212.38% | ๐บ๐ธ USA |